ArticleJournal of neurology2026
Cardiogenic vertigo: clinical characteristics and predictors of long-term prognosis.
Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo elucidate the clinical characteristics and long-term prognosis of cardiogenic vertigo (CV).
methodsWe retrospectively analyzed the clinical characteristics and predictors of long-term outcomes in 82 patients (age range 36-91 years, 72 ± 9.4 years) with CV over a 10-year period at four university hospitals in Korea. All patients underwent both comprehensive vestibular and systematic cardiac evaluation. The follow-up period ranged from 3 to 161 months (median, 41.8 months). Patients received procedural interventions (n = 51, 62%) or medical treatment (n = 31, 38%). Outcomes were analyzed using multivariable logistic regression and Kaplan-Meier survival analysis.
resultsRecurrent vertigo occurred without syncope in 48% of patients and in relation to syncope in the remainder. Episodes were typically brief (seconds in 84%, minutes in 16%) and were accompanied by additional symptoms in 95%. Male sex was more prevalent in the syncope group (p = 0.023), whereas vertigo was more frequent in the non-syncope group (p < 0.05). Sick sinus syndrome predominated in the non-syncope group (p = 0.012), while complete atrioventricular block was observed exclusively in the syncope group (14%). During follow-up, 11 deaths (15%) and 10 vertigo recurrence (13%) were recorded. Male sex is the only independent predictor of mortality (adjusted odds ratio 7.02, p = 0.018), and procedural interventions were associated with lower vertigo recurrence compared with medical treatment alone (p = 0.022).
conclusionCardiovascular disorders may present as recurrent isolated vertigo, with or without syncope. Distinct clinical features can aid in differentiating CV from other vestibular disorders. Male sex appears to be an independent predictor of mortality, and active cardiac intervention reduce vertigo recurrence and improve clinical outcomes.
Indexed as
Identifiers
42554783What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.